Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006

Journal of Hypertension
Mitra EbrahimiMasud Yunesian

Abstract

Assessing hypertension prevalence, treatment and control by sociodemographic factors in Iran. We analyzed data from the 2006 National Surveillance of Risk Factors for Noncommunicable Diseases of Iran with a population-based sample of almost 30,000 people aged 15-64 years. Multiple logistic regression models were used to explore differences in hypertension prevalence, treatment and control, adjusting for sociodemographic factors, comorbidities and behavioral factors. Hypertension prevalence was 17.37%. Among hypertensive patients, 33.35% were under treatment, and, among treated people, 35.10% had hypertension controlled. In multiple-regression analysis, age, male sex, low level of education, Kurd ethnicity, overweight and obesity, diabetes mellitus, lower level of physical activity and high-Human Development Index provinces were independently associated with higher prevalence of hypertension. Income and living in rural or urban area were not related to hypertension prevalence. Treatment rates were lower in men, younger people and people of low education and low income, but there were no treatment rate disparities connected to living area, ethnicity and provinces (by Human Development Index). In addition, diabetic patients, obese...Continue Reading

References

Sep 1, 1991·American Journal of Public Health·E L Korn, B I Graubard
Mar 21, 1998·Journal of Human Hypertension·H M ColhounN R Poulter
Jun 24, 1999·Journal of the National Cancer Institute·B I Graubard, E L Korn
Mar 19, 2002·Hypertension·Karen A MatthewsUNKNOWN Coronary Artery Risk Development in Young Adults Study (CARDIA)
Oct 23, 2002·International Journal of Nursing Practice·Eesa MohammadiFarzad Jalali
Nov 9, 2002·Lancet·Majid EzzatiUNKNOWN Comparative Risk Assessment Collaborating Group
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Ihab Hajjar, Theodore A Kotchen
Oct 25, 2003·Stroke; a Journal of Cerebral Circulation·Stella AslanyanGordon T McInnes
Feb 20, 2004·Journal of Human Hypertension·B WilliamsUNKNOWN British Hypertension Society
Apr 27, 2004·Journal of Hypertension·Patricia M KearneyJiang He
Jun 26, 2004·International Journal of Epidemiology·Theodora PsaltopoulouAntonia Trichopoulou
Nov 20, 2004·Social Science & Medicine·Peymané AdabTai Hing Lam
Mar 17, 2005·Circulation·George A MensahJanet B Croft
Mar 24, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Zengwu WangUNKNOWN Cooperative Research Group of the Study on Trends of Cardiovascular Diseases in China and Preventive Strategy for the 21st C
May 17, 2005·American Heart Journal·Ann M BorzeckiDan R Berlowitz
Oct 31, 2006·American Journal of Hypertension·Michel Burnier
Feb 1, 2008·The Journal of Clinical Hypertension·William J Elliott
Jun 25, 2008·Archives of Internal Medicine·Ronald G VictorRobert W Haley
Sep 24, 2008·American Journal of Public Health·David R Williams
Sep 13, 2008·The International Journal of Social Psychiatry·N MofidiJ Richter

❮ Previous
Next ❯

Citations

Mar 15, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Pietro Amedeo ModestiHusni Al Goshae
Mar 22, 2013·Journal of Human Hypertension·P A ModestiH Al Goshae
May 16, 2013·Journal of Hypertension·Masoud M MalekzadehReza Malekzadeh
Apr 5, 2014·American Journal of Hypertension·Jinwei WangUNKNOWN China National Survey of Chronic Kidney Disease Working Group
Jan 20, 2016·International Journal of Hypertension·Sayed Fazel Zinat MotlaghAmin Babouei
Apr 14, 2016·International Journal of Hypertension·Azin Behnood-RodDonald E Morisky
Jan 23, 2015·Journal of Diabetes and Metabolic Disorders·Shahrzad Jafari-AdliShirin Hasani-Ranjbar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.